$0.08 arrow  Change: 0.08 %Chge: 0.00% Vol: 100,115
End Of Day Prices
High: 0.09 | Low: 0.078 | Open: 0.085 | Close: 0.08
52 Wk High: 0.09 | 52 Wk Low: 0.078 | Todays Pivot: 0.08
Sector: add stock to watch list

BCON Chart

You need Flash Player to see the chart, please download from the link below

Get Adobe Flash player

Online News For Beacon Power

Outcomes of radiosensitisation in elderly patients with advanced bladder cancer.

We evaluated the efficacy and tolerability of concurrent radical radiotherapy with gemcitabine radiosensitisation (GemX) in elderly patients with MIBC and compared outcomes to those from the bladder carbogen and nicotinamide (BCON) phase III trial.

Want To Add This Quote To Your Site?

With our stock widgets you can add a Beacon Power quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for BCON to choose from. Visit here to build your stock quote widget »